Trial intelligence / Profile preview

Remimazolam and Alfentanil for Awake Endotracheal Intubation

NCT06026566Recruiting

Sponsor
Tongji Hospital
Start
Apr 2023
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of remimazolam, sponsored by Tongji Hospital. Started Apr 2023; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on NCT06026566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06026566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call